Endocrinol Metab.  2014 Jun;29(2):202-205. 10.3803/EnM.2014.29.2.202.

Recurrent Hypoglycemia Triggered by Sorafenib Therapy in a Patient with Hemangiopericytoma

• Lee SW
• Lee EK
• Yun T
• Won YW
• Ko EJ
• Choi M
• Choi SI
• Park SS
• Hong EK

• KMID: 2169428
• DOI: http://doi.org/10.3803/EnM.2014.29.2.202

Abstract

Targeted therapy has been proven to be one of the most effective cancer treatments. However, some endocrine disorders can occur during treatment with targeted agents. We report the case of a patient who exhibited a wax and wane pattern of hypoglycemia that was attributed to sorafenib therapy. A 32-year-old woman with metastatic hemangiopericytoma visited the emergency department in a stuporous state. Nonhyperinsulinemic hypoglycemia was diagnosed, was exacerbated shortly after sorafenib therapy, and was improved by the cessation of sorafenib with additional glucocorticoid therapy. Patients with metastatic hemangiopericytoma should be carefully monitored with particular attention to hypoglycemia when sorafenib therapy is initiated.

Keyword

Hemangiopericytoma; Hypoglycemia; Sorafenib

MeSH Terms

Adult
Emergency Service, Hospital
Female
Hemangiopericytoma*
Humans
Hypoglycemia*
Stupor

Reference

1. Lee Y, Jung HS, Choi HJ, Kim MJ, Kim TM, Park KS, Kim SY. Life-threatening hypoglycemia induced by a tyrosine kinase inhibitor in a patient with neuroendocrine tumor: a case report. Diabetes Res Clin Pract. 2011; 93:e68–e70.

2. Agostino NM, Chinchilli VM, Lynch CJ, Koszyk-Szewczyk A, Gingrich R, Sivik J, Drabick JJ. Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. J Oncol Pharm Pract. 2011; 17:197–202.

3. Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmermann's pericytes. Ann Surg. 1942; 116:26–33.

4. Zapf J. Insulinlike growth factor binding proteins and tumor hypoglycemia. Trends Endocrinol Metab. 1995; 6:37–42.

5. Le Jeune S, Des Guetz G, Bihan H, Cohen R, Coindre JM, Mourad JJ. Refractory hypoglycemia controlled by sorafenib in solitary fibrous tumor. J Clin Oncol. 2013; 31:e118–e121.

6. Teale JD. Non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf). 1999; 51:147.

7. Pavelic K, Spaventi S, Gluncic V, Matejcic A, Pavicic D, Karapandza N, Kusic Z, Lukac J, Dohoczky C, Cabrijan T, Pavelic J. The expression and role of insulin-like growth factor II in malignant hemangiopericytomas. J Mol Med (Berl). 1999; 77:865–869.

8. Bell GI, Merryweather JP, Sanchez-Pescador R, Stempien MM, Priestley L, Scott J, Rall LB. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature. 1984; 310:775–777.

9. Froesch ER, Guler HP, Schmid C, Binz K, Zapf J. Therapeutic potential of insulinlike growth factor i. Trends Endocrinol Metab. 1990; 1:254–260.

10. Phillips LS, Robertson DG. Insulin-like growth factors and non-islet cell tumor hypoglycemia. Metabolism. 1993; 42:1093–1101.

11. Billemont B, Medioni J, Taillade L, Helley D, Meric JB, Rixe O, Oudard S. Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib. Br J Cancer. 2008; 99:1380–1382.

12. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ, Braund W. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab. 1995; 80:2700–2708.

13. Chung J, Henry RR. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab. 1996; 81:919–925.

14. Nanayakkara PW, van Doorn J, van den Berg FG, van Groeningen CJ, Pinedo HM, Hoekman K. Treatment of haemangiopericytoma-associated hypoglycaemia with embolisation. Eur J Intern Med. 2002; 13:340–343.

15. Soran H, Younis N, Joseph F, Hayat Z, Zakhour H, Scott A. A case of haemangiopericytoma-associated hypoglycaemia: beneficial effect of treatment with radiotherapy. Int J Clin Pract. 2006; 60:1319–1322.

16. Adams J, Lodge JP, Parker D. Liver transplantation for metastatic hemangiopericytoma associated with hypoglycemia. Transplantation. 1999; 67:488–489.